First Trust Advisors LP Incyte Corp Transaction History

First Trust Advisors LP

$101 Billion
Q3 2024

A detailed history of First Trust Advisors LP transactions in Incyte Corp stock. As of the latest transaction made, First Trust Advisors LP holds 1,144,600 shares of INCY stock, worth $88.1 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

1,144,600

Previous 1,244,048 7.99%

Holding current value

$88.1 Million

Previous $75.4 Million 0.32%

% of portfolio

0.07%

Previous 0.08%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$57.33 - $68.61 $5.7 Million - $6.82 Million	-99,448 Reduced 7.99%	1,144,600 $75.7 Million
Q2 2024 Aug 13, 2024	BUY	$51.18 - $63.75 $17.9 Million - $22.3 Million	350,042 Added 39.15%	1,244,048 $75.4 Million
Q1 2024 May 13, 2024	SELL	$56.55 - $66.59 $1.38 Million - $1.62 Million	-24,352 Reduced 2.65%	894,006 $50.9 Million
Q4 2023 Feb 13, 2024	BUY	$52.16 - $64.19 $5.69 Million - $7 Million	109,069 Added 13.48%	918,358 $57.7 Million
Q3 2023 Nov 13, 2023	BUY	$57.77 - $65.93 $3.61 Million - $4.12 Million	62,508 Added 8.37%	809,289 $46.8 Million
Q2 2023 Aug 14, 2023	SELL	$60.95 - $75.51 $152 Million - $188 Million	-2,493,153 Reduced 76.95%	746,781 $46.5 Million
Q1 2023 May 15, 2023	SELL	$70.23 - $86.01 $9.48 Million - $11.6 Million	-134,985 Reduced 4.0%	3,239,934 $234 Million
Q4 2022 Feb 09, 2023	BUY	$67.18 - $84.11 $160 Million - $201 Million	2,387,445 Added 241.77%	3,374,919 $271 Million
Q3 2022 Nov 14, 2022	SELL	$66.18 - $82.86 $146 Million - $183 Million	-2,213,181 Reduced 69.15%	987,474 $65.8 Million
Q2 2022 Aug 12, 2022	BUY	$66.18 - $83.18 $152 Million - $191 Million	2,290,893 Added 251.81%	3,200,655 $243 Million
Q1 2022 May 13, 2022	SELL	$66.02 - $79.71 $6.31 Million - $7.62 Million	-95,578 Reduced 9.51%	909,762 $72.3 Million
Q4 2021 Feb 08, 2022	SELL	$63.34 - $74.11 $4.01 Million - $4.69 Million	-63,327 Reduced 5.93%	1,005,340 $73.8 Million
Q3 2021 Nov 15, 2021	BUY	$68.67 - $84.02 $6.8 Million - $8.33 Million	99,084 Added 10.22%	1,068,667 $73.5 Million
Q2 2021 Aug 16, 2021	SELL	$79.87 - $87.53 $160,299 - $175,672	-2,007 Reduced 0.21%	969,583 $81.6 Million
Q1 2021 May 14, 2021	BUY	$76.02 - $100.5 $5.67 Million - $7.49 Million	74,549 Added 8.31%	971,590 $79 Million
Q4 2020 Feb 02, 2021	SELL	$80.74 - $97.7 $18.3 Million - $22.1 Million	-226,584 Reduced 20.17%	897,041 $78 Million
Q3 2020 Nov 05, 2020	SELL	$85.07 - $109.69 $69.3 Million - $89.4 Million	-815,193 Reduced 42.05%	1,123,625 $101 Million
Q2 2020 Jul 22, 2020	BUY	$74.18 - $108.93 $57.6 Million - $84.6 Million	776,209 Added 66.76%	1,938,818 $202 Million
Q1 2020 May 06, 2020	BUY	$63.18 - $85.97 $20.7 Million - $28.2 Million	328,035 Added 39.31%	1,162,609 $85.1 Million
Q4 2019 Feb 03, 2020	SELL	$73.04 - $95.72 $23.2 Million - $30.4 Million	-317,644 Reduced 27.57%	834,574 $72.9 Million
Q3 2019 Nov 04, 2019	SELL	$72.82 - $86.52 $51.6 Million - $61.4 Million	-709,190 Reduced 38.1%	1,152,218 $85.5 Million
Q2 2019 Jul 30, 2019	BUY	$73.52 - $88.7 $20.3 Million - $24.5 Million	276,290 Added 17.43%	1,861,408 $158 Million
Q1 2019 May 09, 2019	BUY	$63.56 - $88.17 $6.58 Million - $9.12 Million	103,479 Added 6.98%	1,585,118 $136 Million
Q4 2018 Feb 07, 2019	SELL	$58.5 - $69.94 $3.77 Million - $4.51 Million	-64,459 Reduced 4.17%	1,481,639 $94.2 Million
Q3 2018 Oct 25, 2018	BUY	$61.75 - $74.23 $42.7 Million - $51.3 Million	691,111 Added 80.83%	1,546,098 $107 Million
Q2 2018 Aug 02, 2018	BUY	$60.85 - $83.98 $16.3 Million - $22.4 Million	267,057 Added 45.42%	854,987 $57.3 Million
Q1 2018 Apr 23, 2018	BUY	$83.06 - $100.98 $13.3 Million - $16.2 Million	160,300 Added 37.49%	587,930 $49 Million
Q4 2017 Feb 08, 2018	SELL	$93.56 - $116.6 $3.69 Million - $4.6 Million	-39,437 Reduced 8.44%	427,630 $40.5 Million
Q3 2017 Oct 24, 2017	BUY	$109.15 - $138.27 $51 Million - $64.6 Million	467,067	467,067 $54.5 Million

Others Institutions Holding INCY

# of Institutions

642

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $17.1B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Account

First Trust Advisors LP Incyte Corp Transaction History